List view / Grid view

Professor Paul Workman

Filter the results

 

news

PARP inhibitors could work in larger group of patients

PARP inhibitors that target cancers with mutations in the BRCA…

19 March 2015 | By Victoria White

PARP inhibitors that target cancers with mutations in the BRCA breast cancer genes could also work against tumours with another type of genetic fault...

news

Cancer risk linked to DNA ‘wormholes’

Single-letter genetic variations within parts of the genome once dismissed…

19 February 2015 | By The Institute of Cancer Research

Single-letter genetic variations within parts of the genome once dismissed as ‘junk DNA’ can increase cancer risk through wormhole-like effects on far-off genes, new research shows...

news

Two major studies strengthen case for prostate cancer drug before chemotherapy

Pioneering prostate cancer drug abiraterone significantly extends the lives of…

5 February 2015 | By The Institute of Cancer Research

Pioneering prostate cancer drug abiraterone significantly extends the lives of men with advanced prostate cancer if given before chemotherapy, the results of a major phase III clinical trial have shown...